» Articles » PMID: 16095594

Long-term Homocysteine Exposure Induces Alterations in Spatial Learning, Hippocampal Signalling and Synaptic Plasticity

Overview
Journal Exp Neurol
Specialty Neurology
Date 2005 Aug 13
PMID 16095594
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Abnormally high levels of homocysteine (HCY) have been linked to neurodegenerative diseases, but it remains unclear whether this is the cause or effect of degenerative processes. Here, we investigated the effects of prolonged HCY exposure on cognitive abilities and physiological parameters by injecting rats daily with either 20 or 200 mg/kg HCY over a period of up to 14 weeks. Notwithstanding a significant weight reduction in the 200 mg HCY group, HCY-exposed animals did not show a behavioural deficit when tested repeatedly (in weeks 1, 3, 5, 7 and 13) in a reference memory version of the water maze. Unexpectedly, some improvement in repeated reversal learning was observed in HCY exposed animals compared to controls. Pre-treatment with HCY for 3 weeks before water maze training did not uncover any cognitive alterations. Increased plasma concentrations of HCY were revealed only for the 200 mg HCY group after 14 weeks of injections, but no evidence for DNA damage was obtained. Immunocytochemically, HCY was detected in the brain after 14 weeks of treatment (both 20 and 200 mg/kg), but not after 5 weeks. Bidirectional changes in basic synaptic transmission and long-term potentiation of hippocampal CA1 pyramidal cells were observed at 5, 7 and 14 weeks in both HCY groups, indicative of complex, multifactorial time- and concentration-dependent changes. Overall, it is concluded that healthy adult rats are able to cope with continuous exposure to HCY. While HCY affects growth and neuronal excitability, this does not precipitate into an immediate impairment of cognitive function.

Citing Articles

Blood-based biomarkers in mild behavioral impairment: an updated overview.

Angelopoulou E, Androni X, Villa C, Hatzimanolis A, Scarmeas N, Papageorgiou S Front Neurol. 2025; 16:1534193.

PMID: 39980634 PMC: 11839432. DOI: 10.3389/fneur.2025.1534193.


Middle aged CAMKII-Cre:Cbs mice: a new model for studying perioperative neurocognitive disorders.

Li Z, He M, Dai D, Gao X, Liang H, Xiong L Exp Anim. 2023; 73(1):109-123.

PMID: 37766548 PMC: 10877146. DOI: 10.1538/expanim.23-0065.


The new mechanism of cognitive decline induced by hypertension: High homocysteine-mediated aberrant DNA methylation.

Wan C, Zong R, Chen X Front Cardiovasc Med. 2022; 9:928701.

PMID: 36352848 PMC: 9637555. DOI: 10.3389/fcvm.2022.928701.


Homocysteine in Schizophrenia: Independent Pathogenetic Factor with Prooxidant Activity or Integral Marker of Other Biochemical Disturbances?.

Zhilyaeva T, Piatoikina A, Bavrina A, Kostina O, Zhukova E, Shcherbatyuk T Schizophr Res Treatment. 2021; 2021:7721760.

PMID: 34707909 PMC: 8545596. DOI: 10.1155/2021/7721760.


Hyperhomocysteinemia: Metabolic Role and Animal Studies with a Focus on Cognitive Performance and Decline-A Review.

Nieraad H, Pannwitz N, de Bruin N, Geisslinger G, Till U Biomolecules. 2021; 11(10).

PMID: 34680179 PMC: 8533891. DOI: 10.3390/biom11101546.